Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation in Relation to Time in Therapeutic Range: An Analysis of US Food and Drug Administration Regulatory Data

被引：0
|
作者：
Boesen, Kim [1 ]
Saiz, Luis Carlos [2 ,3 ]
Gotzsche, Peter C. [4 ]
Erviti, Juan [2 ,3 ,5 ]
机构：
[1] Copenhagen Univ Hosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Capital Reg,Rigshospitalet, Copenhagen, Denmark
[2] Navarre Hlth Serv, Unit Innovat & Org, Pamplona, Spain
[3] Navarre Inst Hlth Res IdiSNA, Pamplona, Navarre, Spain
[4] Inst Sci Freedom, Copenhagen, Denmark
[5] Univ Publ Navarra, , Navarre, Pamplona, Spain
来源：
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES | 2025年 / 18卷 / 03期
关键词：
anticoagulants; atrial fibrillation; international normalized ratio; United States Food and Drug Administration; warfarin; NORMALIZED RATIO CONTROL; STROKE PREVENTION; EFFICACY; SAFETY;
D O I：
10.1161/CIRCOUTCOMES.124.011321
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study
    Coons, Eric M.
    Staubes, Britta A.
    Casey, Ashley L.
    Elagizi-Youssef, Stephanie A.
    Mohammed, Alaa E.
    Sharma, Nikhil
    Kline, Elle R.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (05) : 533 - 540
  • [42] Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with valvular atrial fibrillation: A populationbased cohort study
    Dawwas, Ghadeer K.
    Dietrich, Eric A.
    Cuker, Adam
    Barnes, Geoffrey
    Leonard, Charles E.
    Lewis, James
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 642 - 642
  • [43] Quality of Adverse Effect Reporting in the Clinical Trials of Comparing Direct Oral Anticoagulants versus Warfarin in Atrial Fibrillation
    Alkhuzai, Fahad
    Almalki, Hamdan
    Althobiani, Shoaib
    Ali, Majid
    Elrggal, Mahmoud
    ARCHIVES OF PHARMACY PRACTICE, 2018, 9 (03) : 4 - 9
  • [44] Time-in-therapeutic-range defined warfarin and standard dose direct oral anticoagulants in atrial fibrillation: Ischemic stroke, intracranial hemorrhage and death in a nationwide registry study
    Lehto, M.
    Luojus, A.
    Halminen, O.
    Haukka, J.
    Lehtonen, O.
    Tiili, P.
    Aro, A. L.
    Putaala, J.
    Linna, M.
    Mustonen, P.
    Kinnunen, J.
    Niemi, M.
    Hartikainen, J.
    Airaksinen, K. E. J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [45] Prescription Patterns and Outcomes of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation a Real World Analysis
    Kattoor, Ajoe J.
    Pothineni, Naga Venkata K.
    Kovelamudi, Swathi
    Abraham, Annette
    Paydak, Hakan
    Mehta, Jawahar L.
    CIRCULATION, 2018, 138
  • [46] Changes in Time in Therapeutic Range Within a Warfarin Anticoagulation Clinic Following Introduction of Direct Oral Anticoagulants
    Samuel, Preethi
    Cassidy, Kaitlyn
    Lazarevskiy, Pauletta
    Cope, Rebecca
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (06) : 1311 - 1317
  • [47] Meta-Analysis Comparing Left Atrial Appendage Occlusion, Direct Oral Anticoagulants, and Warfarin for Nonvalvular Atrial Fibrillation
    Abdelfattah, Omar M.
    Sayed, Ahmed
    Munir, Malak
    Almotawally, Salma
    Wilson, Karim
    Gad, Mohamed M.
    Abushouk, Abdelrahman I.
    Elsayed, Mahmoud
    Wazni, Oussama M.
    Saliba, Walid I.
    Elgendy, Islam Y.
    Jneid, Hani
    Kapadia, Samir
    AMERICAN JOURNAL OF CARDIOLOGY, 2023, 186 : 117 - 125
  • [48] Analysis of time in therapeutic range (TTR) to evaluate the efficacy of warfarin for patients with atrial fibrillation
    Humphry, N.
    Richard, B.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 278 - 278
  • [49] Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data
    Wei Hu
    Huiya Cai
    Jinhua Zhang
    European Journal of Clinical Pharmacology, 2022, 78 : 1057 - 1067
  • [50] Silent cerebral thromboembolism in catheter ablation for atrial fibrillation under the use of novel oral anticoagulants versus therapeutic warfarin
    Aso, A.
    Nakamura, T.
    Ejima, E.
    Omura, S.
    Inoue, H.
    Mori, T.
    Takenaka, K.
    Numaguchi, K.
    Sato, S.
    Hiyamuta, K.
    EUROPEAN HEART JOURNAL, 2014, 35 : 550 - 550
12345